EBS
Emergent BioSolutions Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.36
−0.31%Forward multiples
Based on analyst estimates
- P/E forward
- 13.80x
- P/E 2026E
- 17.92x
- P/E 2027E
- 6.16x
- P/E 2028E
- 4.11x
- P/S forward
- 0.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.96x
- Price / sales
- 0.42x
- Price / cash flow
- 3.34x
Enterprise value
- Enterprise value
- $768.2M
- EV / sales
- 1.00x
- EV / EBITDA
- -1097.43x
- EV / EBIT
- -14.12x
- Market cap
- $326.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026